Steve Wedge is a cancer pharmacologist who has worked exclusively on the discovery and development of novel oncology therapeutics for over 30 years. He is CSO of Cancer Research Horizons Therapeutic Innovation and Professor of Stratified Cancer Medicine Discovery at Newcastle University. Steve previously worked for AstraZeneca for 16 years, gaining experience across the drug discovery phases; from target selection, lead identification and optimisation, through to translational science and regulatory interactions in early development.